ERBB2 and liposarcoma: Immunohistochemical analysis revealed positive expression of MDM2 (Figure 1D), a liposarcoma marker, along with Vimentin, ER, PR, and Ki67 (Figure 1E-H), while HER-2 and PCK were negative (Figure 1I,J).